Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Базальноклеточный рак кожи

Список литературы

  1. WHO Classification of Skin Tumours. WHO Classification of Tumours, 4th Edition, Volume 11. ‒ 4th изд., 2018. WHO Classification of Tumours, 4th Edition, Volume 11.
  2. Verkouteren J. A. C., Ramdas K. H. R., Wakkee M., Nijsten T. Epidemiology of basal cell carcinoma: scholarly review // Br J Dermatol. ‒ 2017. ‒ T. 177, № 2. ‒ C. 359-372.
  3. Fitzpatrick T. B. The validity and practicality of sun-reactive skin types I through VI // Arch Dermatol. ‒ 1988. ‒ T. 124, № 6. ‒ C. 869-71.
  4. Rosso S., Zanetti R., Martinez C., Tormo M. J., Schraub S., Sancho-Garnier H., Franceschi S., Gafa L., Perea E., Navarro C., Laurent R., Schrameck C., Talamini R., Tumino R., Wechsler J. The multicentre south European study "Helios". II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin // Br J Cancer. ‒ 1996. ‒ T. 73, № 11. ‒ C. 1447-54.
  5. Leffell D. J., Carucci J. A. Management of Skin Cancer // Cancer: Principles and Practice of Oncology / Devita V. T. и др.Lippincott Williams & Wilkins, .
  6. Jayaraman S. S., Rayhan D. J., Hazany S., Kolodney M. S. Mutational landscape of basal cell carcinomas by whole-exome sequencing // J Invest Dermatol. ‒ 2014. ‒ T. 134, № 1. ‒ C. 213-220.
  7. Reifenberger J., Wolter M., Knobbe C. B., Kohler B., Schonicke A., Scharwachter C., Kumar K., Blaschke B., Ruzicka T., Reifenberger G. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas // Br J Dermatol. ‒ 2005. ‒ T. 152, № 1. ‒ C. 43-51.
  8. Lam C., Ou J. C., Billingsley E. M. "PTCH"-ing it together: a basal cell nevus syndrome review // Dermatol Surg. ‒ 2013. ‒ T. 39, № 11. ‒ C. 1557-72.
  9. Rogers H. W., Weinstock M. A., Harris A. R., Hinckley M. R., Feldman S. R., Fleischer A. B., Coldiron B. M. Incidence estimate of nonmelanoma skin cancer in the United States, 2006 // Arch Dermatol. ‒ 2010. ‒ T. 146, № 3. ‒ C. 283-7.
  10. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer // Br J Dermatol. ‒ 2012. ‒ T. 166, № 5. ‒ C. 1069-80.
  11. Rubin A. I., Chen E. H., Ratner D. Basal-cell carcinoma // N Engl J Med. ‒ 2005. ‒ T. 353, № 21. ‒ C. 2262-9.
  12. Kuo K. Y., Batra P., Cho H. G., Li S., Chahal H. S., Rieger K. E., Tang J. Y., Sarin K. Y. Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution // J Am Acad Dermatol. ‒ 2017. ‒ T. 77, № 2. ‒ C. 233-234 e2.
  13. Состояние онкологической помощи населению России в 2018 году /. ‒ М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019.
  14. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность) /. ‒ М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019.
  15. Состояние онкологической помощи населению России в 2022 году /. ‒ Москва: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2023. ‒ 239 с.
  16. Злокачественные новообразования в России в 2022 году (заболеваемость и смертность) /. ‒ Москва: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2023. ‒ 275 с.
  17. Zou Y., Zhao Y., Yu J., Luo X., Han J., Ye Z., Li J., Lin H. Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis // J Cosmet Dermatol. ‒ 2016. ‒ T. 15, № 4. ‒ C. 374-382.
  18. Состояние онкологической помощи населению России в 2017 году /. ‒ М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018.
  19. TNM classification of malignant tumors /. ‒ Oxford, UK: John Wiley & Sons, Inc, 2017.
  20. Bordeaux J., Blitzblau R., Aasi S. Z., Alam M., Amini A., Bibee K., Bolotin D., Chen P. L., Contreras C. M., DiMaio D., Donigan J. M., Farma J. M., Ghosh K., Ho A. L., Lukens J. N., Manber S., Mark L., Medina T., Nehal K. S., Nghiem P., Olino K., Park S., Patel T., Puzanov I., Rich J., Shaha A., Srivastava D., Thomas V., Tomblinson V., Venkat P., Xu Y. G., Yusug M., Espinosa S., McCullough B. Basal cell skin cancer. NCCN clinical practice guidelines in oncology. Version 1.2024 - March 1.2024 //. ‒ 2024. ‒ C. 57.
  21. Badash I., Shauly O., Lui C. G., Gould D. J., Patel K. M. Nonmelanoma Facial Skin Cancer: A Review of Diagnostic Strategies, Surgical Treatment, and Reconstructive Techniques // Clin Med Insights Ear Nose Throat. ‒ 2019. ‒ T. 12. ‒ C. 1179550619865278.
  22. Marzuka A. G., Book S. E. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management // Yale J Biol Med. ‒ 2015. ‒ T. 88, № 2. ‒ C. 167-79.
  23. Renzi M., Jr., Schimmel J., Decker A., Lawrence N. Management of Skin Cancer in the Elderly // Dermatol Clin. ‒ 2019. ‒ T. 37, № 3. ‒ C. 279-286.
  24. Tanese K. Diagnosis and Management of Basal Cell Carcinoma // Curr Treat Options Oncol. ‒ 2019. ‒ T. 20, № 2. ‒ C. 13.
  25. Reggiani C., Zalaudek I., Piana S., Longo C., Argenziano G., Lallas A., Pellacani G., Moscarella E. Fibroepithelioma of Pinkus: case reports and review of the literature // Dermatology. ‒ 2013. ‒ T. 226, № 3. ‒ C. 207-11.
  26. Moreira C., Morais P., Santos P., Castro M., Azevedo F. Phenotypic spectrum of a patient with Gorlin"s syndrome and role of dermoscopy in the early detection of basal cell carcinomas // An Bras Dermatol. ‒ 2015. ‒ T. 90, № 3. ‒ C. 416-9.
  27. Bajdik C. D., Gallagher R. P., Astrakianakis G., Hill G. B., Fincham S., McLean D. I. Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer // Br J Cancer. ‒ 1996. ‒ T. 73, № 12. ‒ C. 1612-4.
  28. Srinivas N., Rachakonda S., Hielscher T., Calderazzo S., Rudnai P., Gurzau E., Koppova K., Fletcher T., Kumar R. Telomere length, arsenic exposure and risk of basal cell carcinoma of skin // Carcinogenesis. ‒ 2019. ‒ T. 40, № 6. ‒ C. 715-723.
  29. deShazo R., Soltani-Arabshahi R., Krishnasamy S., Langley R. G., Kalia S., Stahle M., Langholff W., Goyal K., Fakharzadeh S., Galindo C., Srivastava B., Krueger G. Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) // J Drugs Dermatol. ‒ 2019. ‒ T. 18, № 10. ‒ C. 1059-1060.
  30. Elnahas S., Olson M. T., Kang P., Panchanathan R., Masuda T., Walia R., Zeitouni N. C., Smith M. A., Bremner R. M. Factors associated with skin cancer in lung transplant recipients: A single-center experience // Clin Transplant. ‒ 2019.10.1111/ctr.13718. ‒ C. e13718.
  31. Huang J. T., Coughlin C. C., Hawryluk E. B., Hook K., Humphrey S. R., Kruse L., Lawley L., Al-Sayegh H., London W. B., Marghoob A., Phung T. L., Pope E., Gerami P., Schmidt B., Robinson S., Bartenstein D., Bahrani E., Brahmbhatt M., Chen L., Haddock E., Mansour D., Nguyen J., Raisanen T., Tran G., Travis K., Wolner Z., Eichenfield L. F. Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults // J Pediatr. ‒ 2019. ‒ T. 211. ‒ C. 152-158.
  32. Oliveira W. R. P., Tirico M., Souza A. A. V., Codarin F. R., Silva L. L. C., Festa Neto C. Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients // Int J Dermatol. ‒ 2019. ‒ T. 58, № 4. ‒ C. 440-448.
  33. Oh C. C., Lee H. Y., Tan B. K., Assam P. N., Kee T. Y. S., Pang S. M. Dermatological conditions seen in renal transplant recipients in a Singapore tertiary hospital // Singapore Med J. ‒ 2018. ‒ T. 59, № 10. ‒ C. 519-523.
  34. Collins L., Quinn A., Stasko T. Skin Cancer and Immunosuppression // Dermatol Clin. ‒ 2019. ‒ T. 37, № 1. ‒ C. 83-94.
  35. Lee C. T., Lehrer E. J., Aphale A., Lango M., Galloway T. J., Zaorsky N. G. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients // Cancer. ‒ 2019. ‒ T. 125, № 20. ‒ C. 3582-3594.
  36. Martinez M. F., Mazzuoccolo L. D., Oddo E. M., Iscoff P. V., Muchnik C., Neumann H. P. H., Martin R. S., Fraga A. R., Azurmendi P. J. Co-Inheritance of Autosomal Dominant Polycystic Kidney Disease and Naevoid Basal Cell Carcinoma Syndrome: Effects on Renal Progression // Nephron. ‒ 2018. ‒ T. 140, № 4. ‒ C. 282-288.
  37. Dinnes J., Deeks J. J., Grainge M. J., Chuchu N., Ferrante di Ruffano L., Matin R. N., Thomson D. R., Wong K. Y., Aldridge R. B., Abbott R., et al. Visual inspection for diagnosing cutaneous melanoma in adults // Cochrane Database of Systematic Reviews. ‒ 2018.10.1002/14651858.CD013194 № 12.
  38. Grange F. [Multiple primary melanoma and familial melanoma. Risk evaluation and screening tests. How to evaluate the risk of developing a second melanoma? In what family? Should screening methods be implemented? Which ones and why?] // Ann Dermatol Venereol. ‒ 1995. ‒ T. 122, № 5. ‒ C. 365-71.
  39. Claeson M., Holmstrom P., Hallberg S., Gillstedt M., Gonzalez H., Wennberg A. M., Paoli J. Multiple Primary Melanomas: A Common Occurrence in Western Sweden // Acta Derm Venereol. ‒ 2016.10.2340/00015555-2598.
  40. Moore M. M., Geller A. C., Warton E. M., Schwalbe J., Asgari M. M. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011 // J Am Acad Dermatol. ‒ 2015. ‒ T. 73, № 4. ‒ C. 630-6.
  41. Dinnes J., Deeks J. J., Chuchu N., Matin R. N., Wong K. Y., Aldridge R. B., Durack A., Gulati A., Chan S. A., Johnston L., Bayliss S. E., Leonardi-Bee J., Takwoingi Y., Davenport C., O"Sullivan C., Tehrani H., Williams H. C., Cochrane Skin Cancer Diagnostic Test Accuracy G. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults // Cochrane Database Syst Rev. ‒ 2018. ‒ T. 12. ‒ C. CD011901.
  42. Force U. S. P. S. T., Bibbins-Domingo K., Grossman D. C., Curry S. J., Davidson K. W., Ebell M., Epling J. W., Jr., Garcia F. A., Gillman M. W., Kemper A. R., Krist A. H., Kurth A. E., Landefeld C. S., Mangione C. M., Phillips W. R., Phipps M. G., Pignone M. P., Siu A. L. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement // JAMA. ‒ 2016. ‒ T. 316, № 4. ‒ C. 429-35.
  43. Reiter O., Mimouni I., Gdalevich M., Marghoob A. A., Levi A., Hodak E., Leshem Y. A. The diagnostic accuracy of dermoscopy for basal cell carcinoma: A systematic review and meta-analysis // J Am Acad Dermatol. ‒ 2019. ‒ T. 80, № 5. ‒ C. 1380-1388.
  44. Gassenmaier M., Stec T., Keim U., Leiter U., Eigentler T. K., Metzler G., Garbe C. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry // J Eur Acad Dermatol Venereol. ‒ 2019. ‒ T. 33, № 1. ‒ C. 63-70.
  45. Wernli K. J., Henrikson N. B., Morrison C. C., Nguyen M., Pocobelli G., Blasi P. R. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force // JAMA. ‒ 2016. ‒ T. 316, № 4. ‒ C. 436-47.
  46. Zalaudek I., Ferrara G., Broganelli P., Moscarella E., Mordente I., Giacomel J., Argenziano G. Dermoscopy patterns of fibroepithelioma of pinkus // Arch Dermatol. ‒ 2006. ‒ T. 142, № 10. ‒ C. 1318-22.
  47. Giacomel J., Lallas A., Argenziano G., Reggiani C., Piana S., Apalla Z., Ferrara G., Moscarella E., Longo C., Zalaudek I. Dermoscopy of basosquamous carcinoma // Br J Dermatol. ‒ 2013. ‒ T. 169, № 2. ‒ C. 358-64.
  48. Lallas A., Tzellos T., Kyrgidis A., Apalla Z., Zalaudek I., Karatolias A., Ferrara G., Piana S., Longo C., Moscarella E., Stratigos A., Argenziano G. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma // J Am Acad Dermatol. ‒ 2014. ‒ T. 70, № 2. ‒ C. 303-11.
  49. Kiladze N., Shulaia T., Bulinska A., Abrahamovych L. Dermatoscopic features of pigmented and non-pigmented basal cell carcinoma // Georgian Med News. ‒ 2015. № 238. ‒ C. 50-3.
  50. Lallas A., Apalla Z., Ioannides D., Argenziano G., Castagnetti F., Moscarella E., Longo C., Palmieri T., Ramundo D., Zalaudek I. Dermoscopy in the diagnosis and management of basal cell carcinoma // Future Oncol. ‒ 2015. ‒ T. 11, № 22. ‒ C. 2975-84.
  51. Lallas A., Argenziano G., Ioannides D. Dermoscopy for basal cell carcinoma subtype prediction // Br J Dermatol. ‒ 2016. ‒ T. 175, № 4. ‒ C. 674-5.
  52. Reiter O., Mimouni I., Dusza S., Halpern A. C., Leshem Y. A., Marghoob A. A. Dermoscopic Features of Basal Cell Carcinoma and its Subtypes: A systematic Review // J Am Acad Dermatol. ‒ 2019.10.1016/j.jaad.2019.11.008.
  53. Bichakjian C., Aasi S. Z., Alam M., Andersen J. S., Blitzblau R., Bordeaux J., Bowen G. M., Chen P. L., Contreras C. M., Mackenzie D., Daniels G. A., Decker R., DiMaio D., Farma J. M., Fisher K., Ghosh K., Grekin R., Ho A. L., Howard H. J., Lawrence D., Lewis K., Loss M., Nehal K. S., Nghiem P., Puzanov I., Schmults C. D., Sekulic A., Shaha A., Thomas V., Xu Y. G., Zic J., Dwyer M., Engh A., Hammond L. Basal cell skin cancer. NCCN clinical practice guidelines in oncology. Version 1.2019 - August 31.2018 //. ‒ 2019. ‒ C. 46.
  54. Ferrante di Ruffano L., Dinnes J., Chuchu N., Bayliss S. E., Takwoingi Y., Davenport C., Matin R. N., O"Sullivan C., Roskell D., Deeks J. J., Williams H. C., Cochrane Skin Cancer Diagnostic Test Accuracy G. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults // Cochrane Database Syst Rev. ‒ 2018. ‒ T. 12. ‒ C. CD013187.
  55. Офтальмоонкология. / Бровкина А. Ф. ‒ Москва: Медицина, 2002.
  56. Бровкина А. Ф., Панова И. Е., Саакян С. В. Офтальмоонкология: новое за последние два десятилетия // Вестник офтальмологии. ‒ 2014. ‒ T. 130, № 6. ‒ C. 13-19.
  57. Вальский В. В., Бородин Ю. И., Саакян С. В. Эффективность протонотерапии эпителиальных злокачественных опухолей придаточного аппарата глаза редуцированной суммарной очаговой дозой // Опухоли головы и шеи. ‒ 2016. ‒ T. 1, № 6. ‒ C. 47-48.
  58. Важенина Д. А., Васильев С. А., Дудник С. Н. Рецидивирующий базальноклеточный рак кожи век (особенности клинического течения, лечения) // Российский медицинский журнал. ‒ 2016. ‒ T. 11. ‒ C. 36-43.
  59. Енгибарян М. А., Пустовая И. В., Ульянова Ю. В. Первичная аутопластика в хирургическом лечении опухолей внутреннего угла глаза // Известия ВУЗ Северо-Кавказский Регион Естественные Науки. ‒ 2011. ‒ C. 34-36.
  60. Панова И. Е., Васильев С. А., Семенов Л. Е. Рецидивирующий базальноклеточный рак кожи век // Клиническая офтальмология. ‒ 2006. ‒ T. 7, № 1. ‒ C. 11-14.
  61. Kadouch D. J., Leeflang M. M., Elshot Y. S., Longo C., Ulrich M., van der Wal A. C., Wolkerstorfer A., Bekkenk M. W., de Rie M. A. Diagnostic accuracy of confocal microscopy imaging vs. punch biopsy for diagnosing and subtyping basal cell carcinoma // J Eur Acad Dermatol Venereol. ‒ 2017. ‒ T. 31, № 10. ‒ C. 1641-1648.
  62. Buchwald H. J., Muller A., Kampmeier J., Lang G. K. [Optical coherence tomography versus ultrasound biomicroscopy of conjunctival and eyelid lesions] // Klin Monbl Augenheilkd. ‒ 2003. ‒ T. 220, № 12. ‒ C. 822-9.
  63. Tehranchinia Z., Rahimi H., Ahadi M. S., Ahadi M. S. Aminolevulinic Acid-photodynamic therapy of Basal cell carcinoma and factors affecting the response to treatment: a clinical trial // Indian J Dermatol. ‒ 2013. ‒ T. 58, № 4. ‒ C. 327.
  64. Crowson A. N. Basal cell carcinoma: biology, morphology and clinical implications // Mod Pathol. ‒ 2006. ‒ T. 19 Suppl 2. ‒ C. S127-47.
  65. Husein-ElAhmed H., Fernandez-Pugnaire M. A. Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod // An Bras Dermatol. ‒ 2016. ‒ T. 91, № 6. ‒ C. 764-769.
  66. Lallas A., Argenziano G., Zendri E., Moscarella E., Longo C., Grenzi L., Pellacani G., Zalaudek I. Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring // Expert Rev Anticancer Ther. ‒ 2013. ‒ T. 13, № 5. ‒ C. 541-58.
  67. Abdu Allah A. M. K., Mohammed K. I., Farag A. G. A., Hagag M. M., Essam M., Tayel N. R. Interleukin-6 serum level and gene polymorphism in keloid patients // Cell Mol Biol (Noisy-le-grand). ‒ 2019. ‒ T. 65, № 5. ‒ C. 43-48.
  68. Arima J., Huang C., Rosner B., Akaishi S., Ogawa R. Hypertension: a systemic key to understanding local keloid severity // Wound Repair Regen. ‒ 2015. ‒ T. 23, № 2. ‒ C. 213-21.
  69. Dohi T., Padmanabhan J., Akaishi S., Than P. A., Terashima M., Matsumoto N. N., Ogawa R., Gurtner G. C. The Interplay of Mechanical Stress, Strain, and Stiffness at the Keloid Periphery Correlates with Increased Caveolin-1/ROCK Signaling and Scar Progression // Plast Reconstr Surg. ‒ 2019. ‒ T. 144, № 1. ‒ C. 58e-67e.
  70. Harn H. I., Ogawa R., Hsu C. K., Hughes M. W., Tang M. J., Chuong C. M. The tension biology of wound healing // Exp Dermatol. ‒ 2019. ‒ T. 28, № 4. ‒ C. 464-471.
  71. Hosalkar H., Greenberg J., Gaugler R. L., Garg S., Dormans J. P. Abnormal scarring with keloid formation after osteochondroma excision in children with multiple hereditary exostoses // J Pediatr Orthop. ‒ 2007. ‒ T. 27, № 3. ‒ C. 333-7.
  72. Kim H. D., Hwang S. M., Lim K. R., Jung Y. H., Ahn S. M., Kim Song J. Recurrent Auricular Keloids during Pregnancy // Arch Plast Surg. ‒ 2013. ‒ T. 40, № 1. ‒ C. 70-2.
  73. Kiprono S. K., Chaula B. M., Masenga J. E., Muchunu J. W., Mavura D. R., Moehrle M. Epidemiology of keloids in normally pigmented Africans and African people with albinism: population-based cross-sectional survey // Br J Dermatol. ‒ 2015. ‒ T. 173, № 3. ‒ C. 852-4.
  74. Kouotou E. A., Nansseu J. R., Omona Guissana E., Mendouga Menye C. R., Akpadjan F., Tounkara T. M., Zoung-Kanyi Bissek A. C., Ndjitoyap Ndam E. C. Epidemiology and clinical features of keloids in Black Africans: a nested case-control study from Yaounde, Cameroon // Int J Dermatol. ‒ 2019. ‒ T. 58, № 10. ‒ C. 1135-1140.
  75. Lee C. P. Keloids--their epidemiology and treatment // Int J Dermatol. ‒ 1982. ‒ T. 21, № 9. ‒ C. 504-5.
  76. Marneros A. G., Norris J. E., Olsen B. R., Reichenberger E. Clinical genetics of familial keloids // Arch Dermatol. ‒ 2001. ‒ T. 137, № 11. ‒ C. 1429-34.
  77. Nakashima M., Chung S., Takahashi A., Kamatani N., Kawaguchi T., Tsunoda T., Hosono N., Kubo M., Nakamura Y., Zembutsu H. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population // Nat Genet. ‒ 2010. ‒ T. 42, № 9. ‒ C. 768-71.
  78. Noishiki C., Hayasaka Y., Ogawa R. Sex Differences in Keloidogenesis: An Analysis of 1659 Keloid Patients in Japan // Dermatol Ther (Heidelb). ‒ 2019. ‒ T. 9, № 4. ‒ C. 747-754.
  79. Ogawa R., Okai K., Tokumura F., Mori K., Ohmori Y., Huang C., Hyakusoku H., Akaishi S. The relationship between skin stretching/contraction and pathologic scarring: the important role of mechanical forces in keloid generation // Wound Repair Regen. ‒ 2012. ‒ T. 20, № 2. ‒ C. 149-57.
  80. Quong W. L., Kozai Y., Ogawa R. A Case of Keloids Complicated by Castleman"s Disease: Interleukin-6 as a Keloid Risk Factor // Plast Reconstr Surg Glob Open. ‒ 2017. ‒ T. 5, № 5. ‒ C. e1336.
  81. Scheinpflug J., Hofer C. T., Schmerbeck S. S., Steinfath M., Doka J., Tesfahunegn Y. A., Violet N., Renko K., Gulich K., John T., Schneider M. R., Wistorf E., Schonfelder G., Schulze F. A microphysiological system for studying human bone biology under simultaneous control of oxygen tension and mechanical loading // Lab Chip. ‒ 2023. ‒ T. 23, № 15. ‒ C. 3405-3423.
  82. Zhang T., Huang C., Luo H., Li J., Huang H., Liu X., Zhan S. Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis // Life Sci. ‒ 2021. ‒ T. 271. ‒ C. 119151.
  83. Zheng J. N., Li Y., Yan Y. M., Shi H., Zou T. T., Shao W. Q., Wang Q. Identification and Validation of Key Genes Associated With Systemic Sclerosis-Related Pulmonary Hypertension // Front Genet. ‒ 2020. ‒ T. 11. ‒ C. 816.
  84. Ogawa R. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago // Plast Reconstr Surg. ‒ 2022. ‒ T. 149, № 1. ‒ C. 79e-94e.
  85. Ai J. W., Liu J. T., Pei S. D., Liu Y., Li D. S., Lin H. M., Pei B. The effectiveness of pressure therapy (15-25 mmHg) for hypertrophic burn scars: A systematic review and meta-analysis // Sci Rep. ‒ 2017. ‒ T. 7. ‒ C. 40185.
  86. Atkinson J. A., McKenna K. T., Barnett A. G., McGrath D. J., Rudd M. A randomized, controlled trial to determine the efficacy of paper tape in preventing hypertrophic scar formation in surgical incisions that traverse Langer"s skin tension lines // Plast Reconstr Surg. ‒ 2005. ‒ T. 116, № 6. ‒ C. 1648-56; discussion 1657-8.
  87. Chan K. Y., Lau C. L., Adeeb S. M., Somasundaram S., Nasir-Zahari M. A randomized, placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound // Plast Reconstr Surg. ‒ 2005. ‒ T. 116, № 4. ‒ C. 1013-20; discussion 1021-2.
  88. O"Brien L., Jones D. J. Silicone gel sheeting for preventing and treating hypertrophic and keloid scars // Cochrane Database Syst Rev. ‒ 2013. ‒ T. 2013, № 9. ‒ C. CD003826.
  89. Hsu K. C., Luan C. W., Tsai Y. W. Review of Silicone Gel Sheeting and Silicone Gel for the Prevention of Hypertrophic Scars and Keloids // Wounds. ‒ 2017. ‒ T. 29, № 5. ‒ C. 154-158.
  90. Bath-Hextall  F. J., Perkins W., Bong J., Williams H. C. Interventions for basal cell carcinoma of the skin. // Cochrane Database of Systematic Reviews ‒2007.10.1002/14651858.CD003412.pub2.
  91. Rowe D. E., Carroll R. J., Day C. L., Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up // J Dermatol Surg Oncol. ‒ 1989. ‒ T. 15, № 3. ‒ C. 315-28.
  92. Rowe D. E., Carroll R. J., Day C. L., Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma // J Dermatol Surg Oncol. ‒ 1989. ‒ T. 15, № 4. ‒ C. 424-31.
  93. Avril M. F., Auperin A., Margulis A., Gerbaulet A., Duvillard P., Benhamou E., Guillaume J. C., Chalon R., Petit J. Y., Sancho-Garnier H., Prade M., Bouzy J., Chassagne D. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study // Br J Cancer. ‒ 1997. ‒ T. 76, № 1. ‒ C. 100-6.
  94. Petit J. Y., Avril M. F., Margulis A., Chassagne D., Gerbaulet A., Duvillard P., Auperin A., Rietjens M. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face // Plast Reconstr Surg. ‒ 2000. ‒ T. 105, № 7. ‒ C. 2544-51.
  95. Thissen M. R., Nieman F. H., Ideler A. H., Berretty P. J., Neumann H. A. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck // Dermatol Surg. ‒ 2000. ‒ T. 26, № 8. ‒ C. 759-64.
  96. Kuijpers D. I., Thissen M. R., Berretty P. J., Ideler F. H., Nelemans P. J., Neumann M. H. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma // Dermatol Surg. ‒ 2007. ‒ T. 33, № 5. ‒ C. 579-87.
  97. Bath-Hextall F., Ozolins M., Armstrong S. J., Colver G. B., Perkins W., Miller P. S., Williams H. C., Surgery versus Imiquimod for Nodular Superficial basal cell carcinoma study g. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial // Lancet Oncol. ‒ 2014. ‒ T. 15, № 1. ‒ C. 96-105.
  98. Bozan A., Gode S., Kaya I., Yaman B., Uslu M., Akyildiz S., Apaydin F., Ceylan C., Ozturk G. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face // Dermatol Surg. ‒ 2015. ‒ T. 41, № 7. ‒ C. 761-7.
  99. Newlands C., Currie R., Memon A., Whitaker S., Woolford T. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines // J Laryngol Otol. ‒ 2016. ‒ T. 130, № S2. ‒ C. S125-S132.
  100. Fukumoto T., Fukumoto R., Oka M., Horita N. Comparing Treatments for Basal Cell Carcinoma in Terms of Long-term Treatment-Failure: A Network Meta-analysis // J Eur Acad Dermatol Venereol. ‒ 2019.10.1111/jdv.15796.
  101. Gulleth Y., Goldberg N., Silverman R. P., Gastman B. R. What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature // Plast Reconstr Surg. ‒ 2010. ‒ T. 126, № 4. ‒ C. 1222-31.
  102. Wolf D. J., Zitelli J. A. Surgical margins for basal cell carcinoma // Arch Dermatol. ‒ 1987. ‒ T. 123, № 3. ‒ C. 340-4.
  103. Phan K., Oh L. J., Goyal S., Rutherford T., Yazdabadi A. Recurrence rates following surgical excision of periocular basal cell carcinomas: systematic review and meta-analysis // J Dermatolog Treat. ‒ 2019.10.1080/09546634.2019.1698702. ‒ C. 1-5.
  104. American Academy of D., American College of Mohs S., American Society for Dermatologic Surgery A., American Society for Mohs S., Ad Hoc Task F., Connolly S. M., Baker D. R., Coldiron B. M., Fazio M. J., Storrs P. A., Vidimos A. T., Zalla M. J., Brewer J. D., Begolka W. S., Berger T. G., Bigby M., Bolognia J. L., Brodland D. G., Collins S., Cronin T. A., Jr., Dahl M. V., Grant-Kels J. M., Hanke C. W., Hruza G. J., James W. D., Lober C. W., McBurney E. I., Norton S. A., Roenigk R. K., Wheeland R. G., Wisco O. J. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery // Dermatol Surg. ‒ 2012. ‒ T. 38, № 10. ‒ C. 1582-603.
  105. Barlow J. O., Zalla M. J., Kyle A., DiCaudo D. J., Lim K. K., Yiannias J. A. Treatment of basal cell carcinoma with curettage alone // J Am Acad Dermatol. ‒ 2006. ‒ T. 54, № 6. ‒ C. 1039-45.
  106. Blixt E., Nelsen D., Stratman E. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone // Dermatol Surg. ‒ 2013. ‒ T. 39, № 5. ‒ C. 719-25.
  107. Julian C., Bowers P. W., Pritchard C. A comparative study of the effects of disposable and Volkmann spoon curettes in the treatment of basal cell carcinoma // Br J Dermatol. ‒ 2009. ‒ T. 161, № 6. ‒ C. 1407-9.
  108. Rodriguez-Vigil T., Vazquez-Lopez F., Perez-Oliva N. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation // J Am Acad Dermatol. ‒ 2007. ‒ T. 56, № 1. ‒ C. 91-5.
  109. Drucker A. M., Adam G. P., Rofeberg V., Gazula A., Smith B., Moustafa F., Weinstock M. A., Trikalinos T. A. Treatments of Primary Basal Cell Carcinoma of the Skin: A Systematic Review and Network Meta-analysis // Ann Intern Med. ‒ 2018. ‒ T. 169, № 7. ‒ C. 456-466.
  110. Mendenhall W. M., Amdur R. J., Hinerman R. W., Cognetta A. B., Mendenhall N. P. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck // Laryngoscope. ‒ 2009. ‒ T. 119, № 10. ‒ C. 1994-9.
  111. Hernandez-Machin B., Borrego L., Gil-Garcia M., Hernandez B. H. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments // Int J Dermatol. ‒ 2007. ‒ T. 46, № 5. ‒ C. 453-9.
  112. Veness M. J., Delishaj D., Barnes E. A., Bezugly A., Rembielak A. Current Role of Radiotherapy in Non-melanoma Skin Cancer // Clin Oncol (R Coll Radiol). ‒ 2019. ‒ T. 31, № 11. ‒ C. 749-758.
  113. Hauschild A., Breuninger H., Kaufmann R., Kortmann R. D., Klein M., Werner J., Reifenberger J., Dirschka T., Garbe C. Brief S2k guidelines--Basal cell carcinoma of the skin // J Dtsch Dermatol Ges. ‒ 2013. ‒ T. 11 Suppl 3. ‒ C. 10-5, 11-6.
  114. Rishi A., Hui Huang S., O"Sullivan B., Goldstein D. P., Lu L., Ringash J., Waldron J., Wells W., Sun A., Hope A., Chung P., Giuliani M., Spreafico A., Tong L., Xu W., Bayley A. Outcome following radiotherapy for head and neck basal cell carcinoma with "aggressive" features // Oral Oncol. ‒ 2017. ‒ T. 72. ‒ C. 157-164.
  115. Likhacheva A., Awan M., Barker C. A., Bhatnagar A., Bradfield L., Brady M. S., Buzurovic I., Geiger J. L., Parvathaneni U., Zaky S., Devlin P. M. Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline // Pract Radiat Oncol. ‒ 2019.10.1016/j.prro.2019.10.014.
  116. Grossi Marconi D., da Costa Resende B., Rauber E., de Cassia Soares P., Fernandes J. M. J., Mehta N., Lopes Carvalho A., Kupelian P. A., Chen A. Head and Neck Non-Melanoma Skin Cancer Treated By Superficial X-Ray Therapy: An Analysis of 1021 Cases // PLoS One. ‒ 2016. ‒ T. 11, № 7. ‒ C. e0156544.
  117. van Hezewijk M., Creutzberg C. L., Putter H., Chin A., Schneider I., Hoogeveen M., Willemze R., Marijnen C. A. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: Analysis of 434 cases // Radiother Oncol. ‒ 2010. ‒ T. 95, № 2. ‒ C. 245-9.
  118. Duinkerken C. W., Lohuis P., Crijns M. B., Navran A., Haas R. L. M., Hamming-Vrieze O., Klop W. M. C., van den Brekel M. W. M., Al-Mamgani A. Orthovoltage X-rays for Postoperative Treatment of Resected Basal Cell Carcinoma in the Head and Neck Area // J Cutan Med Surg. ‒ 2017. ‒ T. 21, № 3. ‒ C. 243-249.
  119. Jeannon J. P., Riddle P. J., Irish J., O"Sullivan B., Brown D. H., Gullane P. Prognostic indicators in carcinoma of the nasal vestibule // Clin Otolaryngol. ‒ 2007. ‒ T. 32, № 1. ‒ C. 19-23.
  120. Olschewski T., Bajor K., Lang B., Lang E., Seegenschmiedt M. H. [Radiotherapy of basal cell carcinoma of the face and head: Importance of low dose per fraction on long-term outcome] // J Dtsch Dermatol Ges. ‒ 2006. ‒ T. 4, № 2. ‒ C. 124-30.
  121. Dundar Y., Cannon R. B., Hunt J. P., Monroe M., Suneja G., Hitchcock Y. J. Radiotherapy regimens in patients with nonmelanoma head and neck skin cancers // Int J Dermatol. ‒ 2018. ‒ T. 57, № 4. ‒ C. 441-448.
  122. Lancellotta V., Kovacs G., Tagliaferri L., Perrucci E., Colloca G., Valentini V., Aristei C. Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer // Biomed Res Int. ‒ 2018. ‒ T. 2018. ‒ C. 2178469.
  123. Belaid A., Nasr C., Benna M., Cherif A., Jmour O., Bouguila H., Benna F. Radiation Therapy for Primary Eyelid Cancers in Tunisia // Asian Pac J Cancer Prev. ‒ 2016. ‒ T. 17, № 7. ‒ C. 3643-6.
  124. Lancellotta V., Kovacs G., Tagliaferri L., Perrucci E., Rembielak A., Stingeni L., Tramontana M., Hansel K., Colloca G., Saldi S., Valentini V., Aristei C. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer // J Geriatr Oncol. ‒ 2019. ‒ T. 10, № 3. ‒ C. 514-517.
  125. Jumeau R., Renard-Oldrini S., Courrech F., Buchheit I., Oldrini G., Vogin G., Peiffert D. High dose rate brachytherapy with customized applicators for malignant facial skin lesions // Cancer Radiother. ‒ 2016. ‒ T. 20, № 5. ‒ C. 341-6.
  126. Guinot J. L., Rembielak A., Perez-Calatayud J., Rodriguez-Villalba S., Skowronek J., Tagliaferri L., Guix B., Gonzalez-Perez V., Valentini V., Kovacs G., Gec E. GEC-ESTRO ACROP recommendations in skin brachytherapy // Radiother Oncol. ‒ 2018. ‒ T. 126, № 3. ‒ C. 377-385.
  127. Cognetta A. B., Howard B. M., Heaton H. P., Stoddard E. R., Hong H. G., Green W. H. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients // J Am Acad Dermatol. ‒ 2012. ‒ T. 67, № 6. ‒ C. 1235-41.
  128. Gunaratne D. A., Veness M. J. Efficacy of hypofractionated radiotherapy in patients with non-melanoma skin cancer: Results of a systematic review // J Med Imaging Radiat Oncol. ‒ 2018. ‒ T. 62, № 3. ‒ C. 401-411.
  129. Zaorsky N. G., Lee C. T., Zhang E., Keith S. W., Galloway T. J. Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis // Radiother Oncol. ‒ 2017. ‒ T. 125, № 1. ‒ C. 13-20.
  130. Ferro M., Deodato F., Macchia G., Gentileschi S., Cilla S., Torre G., Padula G. D., Nuzzo M., Massaccesi M., Valentini V., Morganti A. G. Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study // Cancer Invest. ‒ 2015. ‒ T. 33, № 2. ‒ C. 34-8.
  131. Hall V. L., Leppard B. J., McGill J., Kesseler M. E., White J. E., Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy // Clin Radiol. ‒ 1986. ‒ T. 37, № 1. ‒ C. 33-4.
  132. Wang I., Bendsoe N., Klinteberg C. A., Enejder A. M., Andersson-Engels S., Svanberg S., Svanberg K. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial // Br J Dermatol. ‒ 2001. ‒ T. 144, № 4. ‒ C. 832-40.
  133. Basset-Seguin N., Ibbotson S. H., Emtestam L., Tarstedt M., Morton C., Maroti M., Calzavara-Pinton P., Varma S., Roelandts R., Wolf P. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial // Eur J Dermatol. ‒ 2008. ‒ T. 18, № 5. ‒ C. 547-53.
  134. Kuflik E. G. Cryosurgery for skin cancer: 30-year experience and cure rates // Dermatol Surg. ‒ 2004. ‒ T. 30, № 2 Pt 2. ‒ C. 297-300.
  135. Samain A., Boullie M. C., Duval-Modeste A. B., Joly P. Cryosurgery and curettage-cryosurgery for basal cell carcinomas of the mid-face // J Eur Acad Dermatol Venereol. ‒ 2015. ‒ T. 29, № 7. ‒ C. 1291-6.
  136. Rhodes L. E., de Rie M. A., Leifsdottir R., Yu R. C., Bachmann I., Goulden V., Wong G. A., Richard M. A., Anstey A., Wolf P. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma // Arch Dermatol. ‒ 2007. ‒ T. 143, № 9. ‒ C. 1131-6.
  137. Braathen L. R., Szeimies R. M., Basset-Seguin N., Bissonnette R., Foley P., Pariser D., Roelandts R., Wennberg A. M., Morton C. A., International Society for Photodynamic Therapy in D. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005 // J Am Acad Dermatol. ‒ 2007. ‒ T. 56, № 1. ‒ C. 125-43.
  138. Kuijpers D. I., Thissen M. R., Thissen C. A., Neumann M. H. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma // J Drugs Dermatol. ‒ 2006. ‒ T. 5, № 7. ‒ C. 642-5.
  139. Savoia P., Deboli T., Previgliano A., Broganelli P. Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma // Int J Mol Sci. ‒ 2015. ‒ T. 16, № 10. ‒ C. 23300-17.
  140. Berroeta L., Clark C., Dawe R. S., Ibbotson S. H., Fleming C. J. A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma // Br J Dermatol. ‒ 2007. ‒ T. 157, № 2. ‒ C. 401-3.
  141. Szeimies R. M., Ibbotson S., Murrell D. F., Rubel D., Frambach Y., de Berker D., Dummer R., Kerrouche N., Villemagne H., Excilight Study G. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up // J Eur Acad Dermatol Venereol. ‒ 2008. ‒ T. 22, № 11. ‒ C. 1302-11.
  142. Roozeboom M. H., Aardoom M. A., Nelemans P. J., Thissen M. R., Kelleners-Smeets N. W., Kuijpers D. I., Mosterd K. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up // J Am Acad Dermatol. ‒ 2013. ‒ T. 69, № 2. ‒ C. 280-7.
  143. Cosgarea R., Susan M., Crisan M., Senila S. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma // J Eur Acad Dermatol Venereol. ‒ 2013. ‒ T. 27, № 8. ‒ C. 980-4.
  144. Wang H., Xu Y., Shi J., Gao X., Geng L. Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis // Photodermatol Photoimmunol Photomed. ‒ 2015. ‒ T. 31, № 1. ‒ C. 44-53.
  145. Roozeboom M. H., Nelemans P. J., Mosterd K., Steijlen P. M., Arits A. H., Kelleners-Smeets N. W. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial // Br J Dermatol. ‒ 2015. ‒ T. 172, № 3. ‒ C. 739-45.
  146. Roozeboom M. H., Arits A. H., Nelemans P. J., Kelleners-Smeets N. W. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials // Br J Dermatol. ‒ 2012. ‒ T. 167, № 4. ‒ C. 733-56.
  147. Jerjes W., Hamdoon Z., Hopper C. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome // Photodiagnosis Photodyn Ther. ‒ 2017. ‒ T. 19. ‒ C. 22-27.
  148. Buzza H. H., Moriyama L. T., Vollet-Filho J. D., Inada N. M., da Silva A. P., Stringasci M. D., Requena M. B., de Andrade C. T., Blanco K. C., Ramirez D. P., Kurachi C., Salvio A. G., Bagnato V. S. Overall Results for a National Program of Photodynamic Therapy for Basal Cell Carcinoma: A Multicenter Clinical Study to Bring New Techniques to Social Health Care // Cancer Control. ‒ 2019. ‒ T. 26, № 1. ‒ C. 1073274819856885.
  149. Morton C. A., Szeimies R. M., Basset-Seguin N., Calzavara-Pinton P., Gilaberte Y., Haedersdal M., Hofbauer G. F. L., Hunger R. E., Karrer S., Piaserico S., Ulrich C., Wennberg A. M., Braathen L. R. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen"s disease and basal cell carcinomas // J Eur Acad Dermatol Venereol. ‒ 2019. ‒ T. 33, № 12. ‒ C. 2225-2238.
  150. Gomez C., Cobos P., Alberdi E. Methyl aminolevulinate photodynamic therapy after partial debulking in the treatment of superficial and nodular basal cell carcinoma: 3-years follow-up // Photodiagnosis Photodyn Ther. ‒ 2021. ‒ T. 33. ‒ C. 102176.
  151. Wozniak Z., Trzeciakowski W., Chlebicka I., Ziolkowski P. Photodynamic diagnosis and photodynamic therapy in basal cell carcinoma using a novel laser light source // Photodiagnosis Photodyn Ther. ‒ 2020. ‒ T. 31. ‒ C. 101883.
  152. Церковский Д. А., Мазуренко А. Н., Петровская Н. А., Артемьева Т. П. Фотодинамическая терапия базальноклеточного рака кожи с фотосенсибилизатором фотолон // Biomedical Photonics. ‒ 2017. ‒ T. 6, № 1. ‒ C. 12-19.
  153. Chan A. L., Juarez M., Allen R., Volz W., Albertson T. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces // Photodermatol Photoimmunol Photomed. ‒ 2005. ‒ T. 21, № 2. ‒ C. 72-8.
  154. Kochneva E. V., Filonenko E. V., Vakulovskaya E. G., Scherbakova E. G., Seliverstov O. V., Markichev N. A., Reshetnickov A. V. Photosensitizer Radachlorin(R): Skin cancer PDT phase II clinical trials // Photodiagnosis Photodyn Ther. ‒ 2010. ‒ T. 7, № 4. ‒ C. 258-67.
  155. Panaseykin Y. A., Kapinus V. N., Filonenko E. V., Polkin V. V., Sevrukov F. E., Smirnova M. A., Isaev P. A., Ivanov S. A., Kaprin A. D. Photodynamic therapy in treatment of squamous cell carcinoma of oral cavity with chlorine e6 photosensitizer with long-term follow up // Biomedical Photonics. ‒ 2024. ‒ T. 13, № 1. ‒ C. 28-38.
  156. Ярославцева-Исаева Е. В., Каплан М. А., Капинус В. Н., Спиченкова И. С., Шубина А. М., Горанская Е. В. Фотодинамическая терапия в самостоятельном и комбинированном лечении местнораспространенного базальноклеточного рака кожи. Фотодинамическая терапия и фотодиагностика. // Biomedical Photonics. ‒ 2012. ‒ T. 1, № 1. ‒ C. 6-11.
  157. Матвеева О. В. Фотодинамическая терапия рецидива базальноклеточного рака кожи теменной области после лучевой терапии // Biomedical Photonics. ‒ 2016. ‒ T. 5, № 2. ‒ C. 38-40.
  158. Geisse J., Caro I., Lindholm J., Golitz L., Stampone P., Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies // J Am Acad Dermatol. ‒ 2004. ‒ T. 50, № 5. ‒ C. 722-33.
  159. Schulze H. J., Cribier B., Requena L., Reifenberger J., Ferrandiz C., Garcia Diez A., Tebbs V., McRae S. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe // Br J Dermatol. ‒ 2005. ‒ T. 152, № 5. ‒ C. 939-47.
  160. Quirk C., Gebauer K., De"Ambrosis B., Slade H. B., Meng T. C. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study // Cutis. ‒ 2010. ‒ T. 85, № 6. ‒ C. 318-24.
  161. Arits A. H., Mosterd K., Essers B. A., Spoorenberg E., Sommer A., De Rooij M. J., van Pelt H. P., Quaedvlieg P. J., Krekels G. A., van Neer P. A., Rijzewijk J. J., van Geest A. J., Steijlen P. M., Nelemans P. J., Kelleners-Smeets N. W. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial // Lancet Oncol. ‒ 2013. ‒ T. 14, № 7. ‒ C. 647-54.
  162. Jansen M. H. E., Mosterd K., Arits A., Roozeboom M. H., Sommer A., Essers B. A. B., van Pelt H. P. A., Quaedvlieg P. J. F., Steijlen P. M., Nelemans P. J., Kelleners-Smeets N. W. J. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma // J Invest Dermatol. ‒ 2018. ‒ T. 138, № 3. ‒ C. 527-533.
  163. van Loo E., Mosterd K., Krekels G. A., Roozeboom M. H., Ostertag J. U., Dirksen C. D., Steijlen P. M., Neumann H. A., Nelemans P. J., Kelleners-Smeets N. W. Surgical excision versus Mohs" micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up // Eur J Cancer. ‒ 2014. ‒ T. 50, № 17. ‒ C. 3011-20.
  164. Mosterd K., Krekels G. A., Nieman F. H., Ostertag J. U., Essers B. A., Dirksen C. D., Steijlen P. M., Vermeulen A., Neumann H., Kelleners-Smeets N. W. Surgical excision versus Mohs" micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years" follow-up // Lancet Oncol. ‒ 2008. ‒ T. 9, № 12. ‒ C. 1149-56.
  165. Wang X., Wang X., Xiang Z., Zeng Y., Liu F., Shao B., He T., Ma J., Yu S., Liu L. The Clinical Application of 3D-Printed Boluses in Superficial Tumor Radiotherapy // Front Oncol. ‒ 2021. ‒ T. 11. ‒ C. 698773.
  166. Endarko E., Aisyah S., Carina C. C. C., Nazara T., Sekartaji G., Nainggolan A. Evaluation of Dosimetric Properties of Handmade Bolus for Megavoltage Electron and Photon Radiation Therapy // J Biomed Phys Eng. ‒ 2021. ‒ T. 11, № 6. ‒ C. 735-746.
  167. Vyas V., Palmer L., Mudge R., Jiang R., Fleck A., Schaly B., Osei E., Charland P. On bolus for megavoltage photon and electron radiation therapy // Med Dosim. ‒ 2013. ‒ T. 38, № 3. ‒ C. 268-73.
  168. Pampena R., Palmieri T., Kyrgidis A., Ramundo D., Iotti C., Lallas A., Moscarella E., Borsari S., Argenziano G., Longo C. Orthovoltage radiotherapy for nonmelanoma skin cancer (NMSC): Comparison between 2 different schedules // J Am Acad Dermatol. ‒ 2016. ‒ T. 74, № 2. ‒ C. 341-7.
  169. Паньшин Г. А., Рыбаков Ю. Н., Близнюков О. П. Лучевая терапия базальноклеточного рака кожи с использованием близкофокусной рентгентерапии и электонного излучения с энергией 6-12 МэВ // Вестник РНЦРР ‒2015. ‒ T. 15.
  170. Kwan W., Wilson D., Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin // Int J Radiat Oncol Biol Phys. ‒ 2004. ‒ T. 60, № 2. ‒ C. 406-11.
  171. Balamucki C. J., Mancuso A. A., Amdur R. J., Kirwan J. M., Morris C. G., Flowers F. P., Stoer C. B., Cognetta A. B., Mendenhall W. M. Skin carcinoma of the head and neck with perineural invasion // Am J Otolaryngol. ‒ 2012. ‒ T. 33, № 4. ‒ C. 447-54.
  172. Kropp L., Balamucki C. J., Morris C. G., Kirwan J., Cognetta A. B., Stoer C. B., Mendenhall W. M. Mohs resection and postoperative radiotherapy for head and neck cancers with incidental perineural invasion // Am J Otolaryngol. ‒ 2013. ‒ T. 34, № 5. ‒ C. 373-7.
  173. Mendenhall W. M., Ferlito A., Takes R. P., Bradford C. R., Corry J., Fagan J. J., Rinaldo A., Strojan P., Rodrigo J. P. Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion // Oral Oncol. ‒ 2012. ‒ T. 48, № 10. ‒ C. 918-922.
  174. Lin C., Tripcony L., Keller J., Poulsen M., Dickie G. Cutaneous carcinoma of the head and neck with clinical features of perineural infiltration treated with radiotherapy // Clin Oncol (R Coll Radiol). ‒ 2013. ‒ T. 25, № 6. ‒ C. 362-7.
  175. Аппликаторы для офтальмоонкологии. Стронций-90 + Иттрий-90. / Тимофеев Л. В., Саакян С. В., Волошин С. В., Архипов А. Ю. ‒ Москва, 2019. ‒ 172 с.
  176. Chopdar A. Carbon-dioxide laser treatment of eye lid lesions // Trans Ophthalmol Soc U K. ‒ 1985. ‒ T. 104 ( Pt 2). ‒ C. 176-80.
  177. Вальский В. В. Крупнофракционная брахитерапия злокачественных опухолей конъюнктивы // Достижения и перспективы офтальмоонкологии. ‒ Москва, 2001. ‒ C. 98-100.
  178. Бровкина А. Ф. Лучевая терапия в лечении опухолей органа зрения // Клин. офтальмология. ‒ 2003. ‒ T. 4, № 1. ‒ C. 15-19.
  179. Физические, технические, некоторые радиобиологические и медицинские аспекты контактной лучевой (бета ̶ ) терапии. . / Тимофеев Л. В. ‒ Москва, 2016. ‒ 680 с.
  180. Расчетные методы дозиметрии бета-излучения. / Тимофеев Л. В. ‒ Москва: Типография "Вашформат",, 2017. ‒ 240 с.
  181. Laskar S., Gurram L., Laskar S. G., Chaudhari S., Khanna N., Upreti R. Superficial ocular malignancies treated with strontium-90 brachytherapy: long term outcomes // J Contemp Brachytherapy. ‒ 2015. ‒ T. 7, № 5. ‒ C. 369-73.
  182. Lecuona K., Stannard C., Hart G., Rice J., Cook C., Wetter J., Duffield M. The treatment of carcinoma in situ and squamous cell carcinoma of the conjunctiva with fractionated strontium-90 radiation in a population with a high prevalence of HIV // Br J Ophthalmol. ‒ 2015. ‒ T. 99, № 9. ‒ C. 1158-61.
  183. Stannard C., Sauerwein W., Maree G., Lecuona K. Radiotherapy for ocular tumours // Eye (Lond). ‒ 2013. ‒ T. 27, № 2. ‒ C. 119-27.
  184. Khan M. K., Powell S., Cox N., Robson A., Murrant N. Cervical in-transit metastasis from a truncal basal cell carcinoma // BMJ Case Rep. ‒ 2010. ‒ T. 2010.
  185. Kahveci O. K., Okur E., Sahin O., Altuntas A., Okur N., Aktepe F. Metastatic basal cell carcinoma presenting as a neck mass // J Craniofac Surg. ‒ 2010. ‒ T. 21, № 2. ‒ C. 592-4.
  186. Dean N. R., Sweeny L., Magnuson J. S., Carroll W. R., Robinson D., Desmond R. A., Rosenthal E. L. Outcomes of recurrent head and neck cutaneous squamous cell carcinoma // J Skin Cancer. ‒ 2011. ‒ T. 2011. ‒ C. 972497.
  187. Oddone N., Morgan G. J., Palme C. E., Perera L., Shannon J., Wong E., Gebski V., Veness M. J. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival // Cancer. ‒ 2009. ‒ T. 115, № 9. ‒ C. 1883-91.
  188. Coombs A. C., Butler A., Allison R. Metastatic cutaneous squamous cell carcinoma of the parotid gland: prognostic factors // J Laryngol Otol. ‒ 2018. ‒ T. 132, № 3. ‒ C. 264-269.
  189. delCharco J. O., Mendenhall W. M., Parsons J. T., Stringer S. P., Cassisi N. J., Mendenhall N. P. Carcinoma of the skin metastatic to the parotid area lymph nodes // Head Neck. ‒ 1998. ‒ T. 20, № 5. ‒ C. 369-73.
  190. Al-Othman M. O., Mendenhall W. M., Amdur R. J. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage // Am J Otolaryngol. ‒ 2001. ‒ T. 22, № 6. ‒ C. 387-90.
  191. Taylor B. W., Jr., Brant T. A., Mendenhall N. P., Mendenhall W. M., Cassisi N. J., Stringer S. P., Million R. R. Carcinoma of the skin metastatic to parotid area lymph nodes // Head Neck. ‒ 1991. ‒ T. 13, № 5. ‒ C. 427-33.
  192. Veness M. Hypofractionated radiotherapy in older patients with non-melanoma skin cancer: Less is better // Australas J Dermatol. ‒ 2018. ‒ T. 59, № 2. ‒ C. 124-127.
  193. Xie P., Lefrancois P. Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis // J Am Acad Dermatol. ‒ 2018. ‒ T. 79, № 6. ‒ C. 1089-1100 e17.
  194. Jacobsen A. A., Aldahan A. S., Hughes O. B., Shah V. V., Strasswimmer J. Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies // JAMA Dermatol. ‒ 2016. ‒ T. 152, № 7. ‒ C. 816-24.
  195. Doctoroff A., Oberlender S. A., Purcell S. M. Full-face carbon dioxide laser resurfacing in the management of a patient with the nevoid basal cell carcinoma syndrome // Dermatol Surg. ‒ 2003. ‒ T. 29, № 12. ‒ C. 1236-40.
  196. Stockfleth E., Ulrich C., Hauschild A., Lischner S., Meyer T., Christophers E. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod // Eur J Dermatol. ‒ 2002. ‒ T. 12, № 6. ‒ C. 569-72.
  197. Ferreres J. R., Macaya A., Jucgla A., Muniesa C., Prats C., Peyri J. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream // J Eur Acad Dermatol Venereol. ‒ 2006. ‒ T. 20, № 7. ‒ C. 877-8.
  198. Chapas A. M., Gilchrest B. A. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome // J Drugs Dermatol. ‒ 2006. ‒ T. 5, № 2 Suppl. ‒ C. 3-5.
  199. Sekulic A., Migden M. R., Oro A. E., Dirix L., Lewis K. D., Hainsworth J. D., Solomon J. A., Yoo S., Arron S. T., Friedlander P. A., Marmur E., Rudin C. M., Chang A. L., Low J. A., Mackey H. M., Yauch R. L., Graham R. A., Reddy J. C., Hauschild A. Efficacy and safety of vismodegib in advanced basal-cell carcinoma // N Engl J Med. ‒ 2012. ‒ T. 366, № 23. ‒ C. 2171-9.
  200. Chang A. L., Solomon J. A., Hainsworth J. D., Goldberg L., McKenna E., Day B. M., Chen D. M., Weiss G. J. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib // J Am Acad Dermatol. ‒ 2014. ‒ T. 70, № 1. ‒ C. 60-9.
  201. Dreno B., Basset-Seguin N., Caro I., Yue H., Schadendorf D. Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma // Oncologist. ‒ 2014. ‒ T. 19, № 8. ‒ C. 790-6.
  202. Basset-Seguin N., Hauschild A., Grob J. J., Kunstfeld R., Dreno B., Mortier L., Ascierto P. A., Licitra L., Dutriaux C., Thomas L., Jouary T., Meyer N., Guillot B., Dummer R., Fife K., Ernst D. S., Williams S., Fittipaldo A., Xynos I., Hansson J. Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial // Lancet Oncol. ‒ 2015. ‒ T. 16, № 6. ‒ C. 729-36.
  203. Sekulic A., Migden M. R., Lewis K., Hainsworth J. D., Solomon J. A., Yoo S., Arron S. T., Friedlander P. A., Marmur E., Rudin C. M., Chang A. L., Dirix L., Hou J., Yue H., Hauschild A., investigators E. B. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC // J Am Acad Dermatol. ‒ 2015. ‒ T. 72, № 6. ‒ C. 1021-6 e8.
  204. Sekulic A., Migden M. R., Basset-Seguin N., Garbe C., Gesierich A., Lao C. D., Miller C., Mortier L., Murrell D. F., Hamid O., Quevedo J. F., Hou J., McKenna E., Dimier N., Williams S., Schadendorf D., Hauschild A., Investigators E. B. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study // BMC Cancer. ‒ 2017. ‒ T. 17, № 1. ‒ C. 332.
  205. Basset-Seguin N., Hauschild A., Kunstfeld R., Grob J., Dreno B., Mortier L., Ascierto P. A., Licitra L., Dutriaux C., Thomas L., Meyer N., Guillot B., Dummer R., Arenberger P., Fife K., Raimundo A., Dika E., Dimier N., Fittipaldo A., Xynos I., Hansson J. Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial // Eur J Cancer. ‒ 2017. ‒ T. 86. ‒ C. 334-348.
  206. Tang J. Y., Ally M. S., Chanana A. M., Mackay-Wiggan J. M., Aszterbaum M., Lindgren J. A., Ulerio G., Rezaee M. R., Gildengorin G., Marji J., Clark C., Bickers D. R., Epstein E. H., Jr. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial // Lancet Oncol. ‒ 2016. ‒ T. 17, № 12. ‒ C. 1720-1731.
  207. Dreno B., Kunstfeld R., Hauschild A., Fosko S., Zloty D., Labeille B., Grob J. J., Puig S., Gilberg F., Bergstrom D., Page D. R., Rogers G., Schadendorf D. Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial // Lancet Oncol. ‒ 2017. ‒ T. 18, № 3. ‒ C. 404-412.
  208. Herms F., Lambert J., Grob J. J., Haudebourg L., Bagot M., Dalac S., Dutriaux C., Guillot B., Jeudy G., Mateus C., Monestier S., Mortier L., Poulalhon N., Prey S., Robert C., Vabres P., Lebbe C., Meyer N., Basset-Seguin N. Follow-Up of Patients With Complete Remission of Locally Advanced Basal Cell Carcinoma After Vismodegib Discontinuation: A Multicenter French Study of 116 Patients // J Clin Oncol. ‒ 2019. ‒ T. 37, № 34. ‒ C. 3275-3282.
  209. Silver J. K., Baima J. Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes // Am J Phys Med Rehabil. ‒ 2013. ‒ T. 92, № 8. ‒ C. 715-27.
  210. Nilsson H., Angeras U., Bock D., Borjesson M., Onerup A., Fagevik Olsen M., Gellerstedt M., Haglind E., Angenete E. Is preoperative physical activity related to post-surgery recovery? A cohort study of patients with breast cancer // BMJ Open. ‒ 2016. ‒ T. 6, № 1. ‒ C. e007997.
  211. Siegel G. W., Biermann J. S., Chugh R., Jacobson J. A., Lucas D., Feng M., Chang A. C., Smith S. R., Wong S. L., Hasen J. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework // J Multidiscip Healthc. ‒ 2015. ‒ T. 8. ‒ C. 109-15.
  212. Shehadeh A., El Dahleh M., Salem A., Sarhan Y., Sultan I., Henshaw R. M., Aboulafia A. J. Standardization of rehabilitation after limb salvage surgery for sarcomas improves patients" outcome // Hematol Oncol Stem Cell Ther. ‒ 2013. ‒ T. 6, № 3-4. ‒ C. 105-11.
  213. Cox C. L., Montgomery M., Oeffinger K. C., Leisenring W., Zeltzer L., Whitton J. A., Mertens A. C., Hudson M. M., Robison L. L. Promoting physical activity in childhood cancer survivors: results from the Childhood Cancer Survivor Study // Cancer. ‒ 2009. ‒ T. 115, № 3. ‒ C. 642-54.
  214. Committee. N. M. A. Topic: The Diagnosis and Treatment of Lymphedema. Position Statement of the National Lymphedema Network. // Book Topic: The Diagnosis and Treatment of Lymphedema. Position Statement of the National Lymphedema Network. / Editor, 2011. ‒ C. 1-19.
  215. Stout N. L., Baima J., Swisher A. K., Winters-Stone K. M., Welsh J. A Systematic Review of Exercise Systematic Reviews in the Cancer Literature (2005-2017) // PM R. ‒ 2017. ‒ T. 9, № 9S2. ‒ C. S347-S384.
  216. Hu M., Lin W. Effects of exercise training on red blood cell production: implications for anemia // Acta Haematol. ‒ 2012. ‒ T. 127, № 3. ‒ C. 156-64.
  217. Bland K. A., Zadravec K., Landry T., Weller S., Meyers L., Campbell K. L. Impact of exercise on chemotherapy completion rate: A systematic review of the evidence and recommendations for future exercise oncology research // Crit Rev Oncol Hematol. ‒ 2019. ‒ T. 136. ‒ C. 79-85.
  218. Streckmann F., Zopf E. M., Lehmann H. C., May K., Rizza J., Zimmer P., Gollhofer A., Bloch W., Baumann F. T. Exercise intervention studies in patients with peripheral neuropathy: a systematic review // Sports Med. ‒ 2014. ‒ T. 44, № 9. ‒ C. 1289-304.
  219. Lee J. M., Look R. M., Turner C., Gardiner S. K., Wagie T., Douglas J., Sorenson L., Evans L., Kirchner S., Dashkoff C., Garrett K., Johnson N. Low-level laser therapy for chemotherapy-induced peripheral neuropathy // Journal of Clinical Oncology. ‒ 2012. ‒ T. 30, № 15_suppl. ‒ C. 9019-9019.
  220. Rick O., von Hehn U., Mikus E., Dertinger H., Geiger G. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study // Bioelectromagnetics. ‒ 2017. ‒ T. 38, № 2. ‒ C. 85-94.
  221. Kilinc M., Livanelioglu A., Yildirim S. A., Tan E. Effects of transcutaneous electrical nerve stimulation in patients with peripheral and central neuropathic pain // J Rehabil Med. ‒ 2014. ‒ T. 46, № 5. ‒ C. 454-60.
  222. Oberoi S., Zamperlini-Netto G., Beyene J., Treister N. S., Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis // PLoS One. ‒ 2014. ‒ T. 9, № 9. ‒ C. e107418.
  223. Westphal J. G., Schulze P. C. Exercise training in cancer related cardiomyopathy // J Thorac Dis. ‒ 2018. ‒ T. 10, № Suppl 35. ‒ C. S4391-S4399.
  224. Ross M., Fischer-Cartlidge E. Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia // Clin J Oncol Nurs. ‒ 2017. ‒ T. 21, № 2. ‒ C. 226-233.
  225. Kessels E., Husson O., van der Feltz-Cornelis C. M. The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis // Neuropsychiatr Dis Treat. ‒ 2018. ‒ T. 14. ‒ C. 479-494.
  226. Rief H., Omlor G., Akbar M., Welzel T., Bruckner T., Rieken S., Haefner M. F., Schlampp I., Gioules A., Habermehl D., von Nettelbladt F., Debus J. Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial // BMC Cancer. ‒ 2014. ‒ T. 14. ‒ C. 67.
  227. Bensadoun R. J., Nair R. G. Low-Level Laser Therapy in the Management of Mucositis and Dermatitis Induced by Cancer Therapy // Photomed Laser Surg. ‒ 2015. ‒ T. 33, № 10. ‒ C. 487-91.
  228. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response // Soc Sci Med. ‒ 1985. ‒ T. 20, № 8. ‒ C. 833-40.
  229. Dirksen S. R. Perceived well-being in malignant melanoma survivors // Oncol Nurs Forum. ‒ 1989. ‒ T. 16, № 3. ‒ C. 353-8.
  230. Lichtenthal W. G., Cruess D. G., Schuchter L. M., Ming M. E. Psychosocial factors related to the correspondence of recipient and provider perceptions of social support among patients diagnosed with or at risk for malignant melanoma // J Health Psychol. ‒ 2003. ‒ T. 8, № 6. ‒ C. 705-19.
  231. Sollner W., Zschocke I., Zingg-Schir M., Stein B., Rumpold G., Fritsch P., Augustin M. Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness // Psychosomatics. ‒ 1999. ‒ T. 40, № 3. ‒ C. 239-50.
  232. Devine D., Parker P. A., Fouladi R. T., Cohen L. The association between social support, intrusive thoughts, avoidance, and adjustment following an experimental cancer treatment // Psychooncology. ‒ 2003. ‒ T. 12, № 5. ‒ C. 453-62.
  233. Folkman S., Lazarus R. S., Gruen R. J., DeLongis A. Appraisal, coping, health status, and psychological symptoms // J Pers Soc Psychol. ‒ 1986. ‒ T. 50, № 3. ‒ C. 571-9.
  234. Онкопсихология для врачей-онкологов и медицинских психологов. Руководство /. ‒ СПб: Любавич, 2017. ‒ 352 с.
  235. Fawzy F. I., Cousins N., Fawzy N. W., Kemeny M. E., Elashoff R., Morton D. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance // Arch Gen Psychiatry. ‒ 1990. ‒ T. 47, № 8. ‒ C. 720-5.
  236. Holland J. C., Passik S., Kash K. M., Russak S. M., Gronert M. K., Sison A., Lederberg M., Fox B., Baider L. The role of religious and spiritual beliefs in coping with malignant melanoma // Psychooncology. ‒ 1999. ‒ T. 8, № 1. ‒ C. 14-26.
  237. Baider L., Perry S., Sison A., Holland J., Uziely B., DeNour A. K. The role of psychological variables in a group of melanoma patients. An Israeli sample // Psychosomatics. ‒ 1997. ‒ T. 38, № 1. ‒ C. 45-53.
  238. Lehto U. S., Ojanen M., Kellokumpu-Lehtinen P. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients // Ann Oncol. ‒ 2005. ‒ T. 16, № 5. ‒ C. 805-16.
  239. Fawzy F. I., Fawzy N. W., Hyun C. S., Elashoff R., Guthrie D., Fahey J. L., Morton D. L. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later // Arch Gen Psychiatry. ‒ 1993. ‒ T. 50, № 9. ‒ C. 681-9.
  240. Fawzy F. I., Kemeny M. E., Fawzy N. W., Elashoff R., Morton D., Cousins N., Fahey J. L. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures // Arch Gen Psychiatry. ‒ 1990. ‒ T. 47, № 8. ‒ C. 729-35.
  241. Fawzy F. I., Canada A. L., Fawzy N. W. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up // Arch Gen Psychiatry. ‒ 2003. ‒ T. 60, № 1. ‒ C. 100-3.
  242. Boesen E. H., Boesen S. H., Frederiksen K., Ross L., Dahlstrom K., Schmidt G., Naested J., Krag C., Johansen C. Survival after a psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study // J Clin Oncol. ‒ 2007. ‒ T. 25, № 36. ‒ C. 5698-703.
  243. Boesen E. H., Ross L., Frederiksen K., Thomsen B. L., Dahlstrom K., Schmidt G., Naested J., Krag C., Johansen C. Psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study // J Clin Oncol. ‒ 2005. ‒ T. 23, № 6. ‒ C. 1270-7.
  244. McLoone J., Menzies S., Meiser B., Mann G. J., Kasparian N. A. Psycho-educational interventions for melanoma survivors: a systematic review // Psychooncology. ‒ 2013. ‒ T. 22, № 7. ‒ C. 1444-56.
  245. Sample A., He Y. Y. Mechanisms and prevention of UV-induced melanoma // Photodermatol Photoimmunol Photomed. ‒ 2018. ‒ T. 34, № 1. ‒ C. 13-24.
  246. Craig S., Earnshaw C. H., Viros A. Ultraviolet light and melanoma // J Pathol. ‒ 2018. ‒ T. 244, № 5. ‒ C. 578-585.
  247. Runger T. M. Mechanisms of Melanoma Promotion by Ultraviolet Radiation // J Invest Dermatol. ‒ 2016. ‒ T. 136, № 9. ‒ C. 1751-1752.
  248. Green A. C., Williams G. M., Logan V., Strutton G. M. Reduced melanoma after regular sunscreen use: randomized trial follow-up // J Clin Oncol. ‒ 2011. ‒ T. 29, № 3. ‒ C. 257-63.
  249. Ghiasvand R., Weiderpass E., Green A. C., Lund E., Veierod M. B. Sunscreen Use and Subsequent Melanoma Risk: A Population-Based Cohort Study // J Clin Oncol. ‒ 2016. ‒ T. 34, № 33. ‒ C. 3976-3983.
  250. Marcil I., Stern R. S. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis // Arch Dermatol. ‒ 2000. ‒ T. 136, № 12. ‒ C. 1524-30.
  251. Kiiski V., de Vries E., Flohil S. C., Bijl M. J., Hofman A., Stricker B. H., Nijsten T. Risk factors for single and multiple basal cell carcinomas // Arch Dermatol. ‒ 2010. ‒ T. 146, № 8. ‒ C. 848-55.
  252. Sanchez G., Nova J., Rodriguez-Hernandez A. E., Medina R. D., Solorzano-Restrepo C., Gonzalez J., Olmos M., Godfrey K., Arevalo-Rodriguez I. Sun protection for preventing basal cell and squamous cell skin cancers // Cochrane Database Syst Rev. ‒ 2016. ‒ T. 7. ‒ C. CD011161.
  253. Badertscher N., Meier M., Rosemann T., Braun R., Cozzio A., Tag B., Wensing M., Tandjung R. The role of skin self-examination at the Swiss skin cancer day // BMC Health Serv Res. ‒ 2014. ‒ T. 14. ‒ C. 581.
  254. Wu S., Han J., Li W. Q., Li T., Qureshi A. A. Basal-cell carcinoma incidence and associated risk factors in U.S. women and men // Am J Epidemiol. ‒ 2013. ‒ T. 178, № 6. ‒ C. 890-7.
  255. Karagas M. R., Stukel T. A., Greenberg E. R., Baron J. A., Mott L. A., Stern R. S. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group // JAMA. ‒ 1992. ‒ T. 267, № 24. ‒ C. 3305-10.
  256. Ramachandran S., Rajaratnam R., Smith A. G., Lear J. T., Strange R. C. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma // J Am Acad Dermatol. ‒ 2009. ‒ T. 61, № 2. ‒ C. 247-51.
  257. Flohil S. C., Koljenovic S., de Haas E. R., Overbeek L. I., de Vries E., Nijsten T. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands // Br J Dermatol. ‒ 2011. ‒ T. 165, № 4. ‒ C. 874-81.
  258. Flohil S. C., van der Leest R. J., Arends L. R., de Vries E., Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis // Eur J Cancer. ‒ 2013. ‒ T. 49, № 10. ‒ C. 2365-75.
  259. Schneider J. The teaspoon rule of applying sunscreen // Arch Dermatol. ‒ 2002. ‒ T. 138, № 6. ‒ C. 838-9.
  260. Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., Carbone P. P. Toxicity and response criteria of the Eastern Cooperative Oncology Group // Am J Clin Oncol. ‒ 1982. ‒ T. 5, № 6. ‒ C. 649-55.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*